Lexaria Bioscience Corp Cash Flow-to-Debt Ratio
Lexaria Bioscience Corp cash flow-to-debt ratio. Lexaria Bioscience Corp (LEXXW) has a Cash Flow-to-Debt Ratio of -0.64x as of November 2025, meaning its operating cash flow of $-984.10K could theoretically repay -1% of its total liabilities ($1.53 Million) in one year. Check LEXXW cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Lexaria Bioscience Corp (2005–2025)
Cash flow-to-debt ratio of Lexaria Bioscience Corp from 2005 to 2025. Historical debt coverage capacity for Lexaria Bioscience Corp across 21 annual periods. Check cash flow reinvestment rate of Lexaria Bioscience Corp to assess the company's total reinvestment commitment from operating cash flow.
Lexaria Bioscience Corp Cash Flow-to-Debt Ratio by Year (2005–2025)
Lexaria Bioscience Corp cash flow-to-debt ratio by year from 2005 to 2025. Year-by-year debt coverage analysis for Lexaria Bioscience Corp. For the full cash flow conversion analysis, see LEXXW operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -6.65x | $-10.45 Million | $1.57 Million | ▼ -62.0% |
| 2024 | -4.10x | $-4.96 Million | $1.21 Million | ▲ +71.8% |
| 2023 | -14.56x | $-5.88 Million | $403.91K | ▲ +39.9% |
| 2022 | -24.22x | $-4.88 Million | $201.44K | ▼ -23.4% |
| 2021 | -19.63x | $-3.99 Million | $203.26K | ▼ -159.3% |
| 2020 | -7.57x | $-2.62 Million | $345.98K | ▲ +53.5% |
| 2019 | -16.29x | $-3.01 Million | $184.51K | ▲ +71.8% |
| 2018 | -57.70x | $-2.52 Million | $43.64K | ▼ -244.7% |
| 2017 | -16.74x | $-1.55 Million | $92.35K | ▼ -1113.1% |
| 2016 | -1.38x | $-660.86K | $478.88K | ▲ +94.9% |
| 2015 | -27.23x | $-1.50 Million | $55.12K | ▼ -12607.3% |
| 2014 | 0.22x | $321.00K | $1.47 Million | ▲ +0.0% |
| 2013 | 0.22x | $321.00K | $1.47 Million | ▼ -1.1% |
| 2012 | 0.22x | $321.00K | $1.46 Million | ▲ +171.8% |
| 2011 | 0.08x | $135.94K | $1.68 Million | ▲ +8.9% |
| 2010 | 0.07x | $109.84K | $1.48 Million | ▲ +127.3% |
| 2009 | -0.27x | $-330.34K | $1.21 Million | ▼ -489.6% |
| 2008 | -0.05x | $-36.40K | $788.18K | ▼ -163.8% |
| 2007 | 0.07x | $29.04K | $400.98K | ▲ +166.7% |
| 2006 | -0.11x | $-218.56K | $2.01 Million | ▲ +99.2% |
| 2005 | -13.72x | $-153.38K | $11.18K | — |